Palo Alto Healthcare

Freespira, formerly known as Palo Alto Health Sciences, is a commercial-stage medical technology company focused on treating mental health conditions through physiological intervention. The company's flagship product, Freespira, is an FDA-cleared digital therapeutic that addresses the underlying physiological causes of panic disorder and PTSD by normalizing breathing patterns and carbon dioxide levels. Unlike traditional pharmacological treatments or psychotherapy, Freespira is a 28-day at-home program that uses a proprietary sensor and tablet-based app to provide real-time biofeedback. The company primarily partners with health plans and employers to provide its clinically validated, non-drug treatment option to patients suffering from chronic anxiety-related conditions.